CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 3, 2025 · Phase 2 readout

ABBV Phase 2 readout: a negative outcome, -9.0%

On February 3, 2025, BOTOX — AbbVie Inc. (Masseter Muscle Prominence) reached its Phase 2 readout. The result was a negative outcome, and the stock moved -9.0% in the window around the event.

The move

$209.03
1d before
$190.14
Event day
$189.95
1d after
$190.60
5d after

Pre-catalyst setup

+1.5%
30-day run-up
5679%
30-day volatility
7.3×
volume spike